Tsubota Laboratory Incorporated (TYO:4890)
Japan · Delayed Price · Currency is JPY 277.00
-4.00 (-1.42%)
Aug 21, 2026, 3:30 PM JST
Tsubota Laboratory Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 390.58 | 200 | 1,357 | 673 | 954 | 640 | |
Revenue Growth | -71.20% | -85.26% | 101.63% | -29.45% | 49.06% | -6.84% |
Cost of Revenue | 228.89 | 68 | 180 | 653 | 235 | 84 |
Gross Profit | 161.69 | 132 | 1,177 | 20 | 719 | 556 |
Selling, General & Admin | 902.53 | 620 | 663 | 435 | 394 | 276 |
Research & Development | - | 279 | 254 | 205 | 126 | 116 |
Operating Expenses | 900.94 | 919 | 941 | 670 | 552 | 420 |
Operating Income | -739.26 | -787 | 236 | -650 | 167 | 136 |
Interest Expense | -0.65 | - | -1 | -1 | - | -1 |
Interest & Investment Income | 3.42 | 3 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.39 | - | 38 | - | -6 | - |
Other Non Operating Income (Expenses) | 43.41 | 23 | 7 | 14 | -17 | 67 |
EBT Excluding Unusual Items | -692.68 | -761 | 280 | -637 | 144 | 202 |
Pretax Income | -692.63 | -761 | 280 | -637 | 144 | 202 |
Income Tax Expense | 1.01 | - | 75 | 4 | 54 | 49 |
Net Income | -693.63 | -761 | 205 | -641 | 90 | 153 |
Net Income to Common | -693.63 | -761 | 205 | -641 | 90 | 153 |
Net Income Growth | - | - | - | - | -41.18% | -23.88% |
Shares Outstanding (Basic) | 26 | 26 | 26 | 25 | 25 | 23 |
Shares Outstanding (Diluted) | 26 | 26 | 26 | 25 | 26 | 23 |
Shares Change | 0.53% | -0.49% | 1.52% | -0.28% | 12.97% | 0.70% |
EPS (Basic) | -26.89 | -29.55 | 8.01 | -25.14 | 3.66 | 6.76 |
EPS (Diluted) | -26.89 | -29.55 | 7.92 | -25.14 | 3.52 | 6.76 |
EPS Growth | - | - | - | - | -47.93% | -24.41% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -585 | -330 | -313 | -16 | 582 |
Free Cash Flow Per Share | - | -22.71 | -12.75 | -12.28 | -0.63 | 25.71 |
Gross Margin | 41.40% | 66.00% | 86.73% | 2.97% | 75.37% | 86.88% |
Operating Margin | -189.27% | -393.50% | 17.39% | -96.58% | 17.51% | 21.25% |
Profit Margin | -177.59% | -380.50% | 15.11% | -95.25% | 9.43% | 23.91% |
Free Cash Flow Margin | - | -292.50% | -24.32% | -46.51% | -1.68% | 90.94% |
EBITDA | -718.15 | -767 | 264 | -615 | 206 | 173 |
EBITDA Margin | -183.87% | - | 19.45% | -91.38% | 21.59% | 27.03% |
D&A For EBITDA | 21.11 | 20 | 28 | 35 | 39 | 37 |
EBIT | -739.26 | -787 | 236 | -650 | 167 | 136 |
EBIT Margin | -189.27% | - | 17.39% | -96.58% | 17.51% | 21.25% |
Effective Tax Rate | - | - | 26.79% | - | 37.50% | 24.26% |